This study is currently not recruiting participants.

The Pathology Core of the Parkinson's Progression Marker Initiative (PPMI)

Investigation of Indicators for Parkinson's Disease Onset

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to identify clinical, imaging, and biologic markers of Parkinson's disease onset.

Detailed description of study

The purpose of this study is to identify clinical, imaging, and biologic markers of Parkinson's disease onset.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinson's disease
  • Age: 100 years or below
  • Gender: All

This study investigates the identification of clinical, imaging, and biological markers for the onset of Parkinson's disease. Parkinson's disease is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. Identifying markers can help understand when the disease begins.

Participants will undergo various procedures including clinical assessments, imaging tests, and biological sampling. Imaging tests may include scans that take pictures of the brain, while biological sampling involves collecting samples like blood or saliva to study changes that might indicate the onset of Parkinson's disease.

  • Who can participate: Participants should be adults aged 18 years and older who have not been diagnosed with Parkinson's disease but may be at risk due to family history or early symptoms.
  • Study details: Participants will be involved in clinical assessments and may provide biological samples such as blood or saliva. Imaging tests may include brain scans.
Updated on 19 Feb 2024. Study ID: 1704075794

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team